Stocks
ANI Pharmaceuticals (ANIP) P/E US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | 119.8 | -15.4 | -13.6 | -13.7 | 52.9 | -171.2 | ||
| Changes by years, y/y, % | +250% | -113% | -12% | +0% | -487% | +9.1% | |||
ANI Pharmaceuticals. P/E
ANI Pharmaceuticals. P/E, changes, %
ANI Pharmaceuticals (ANIP) P/E US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/E | ? | 81.9 | 55.8 | 37.1 | 45.5 | -163.3 | -171.2 | |
| Changes by years, y/y, % | -1 581% | -507% | -250% | -125% | -299% | |||
| Changes by quarters, q/q, % | -144% | -32% | -33% | +23% | -458% | |||
